Zeposia (ozanimod)

Targeted Conditions

  • Relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
  • Moderately to severely active ulcerative colitis (UC) in adults.

Off-Label Usage

  • Investigated in Crohn’s disease (not yet approved).
  • Studied for other immune-mediated conditions where lymphocyte modulation may be beneficial.

Drug Classification Overview

Zeposia is a sphingosine 1-phosphate (S1P) receptor modulator. It works by preventing certain white blood cells (lymphocytes) from leaving lymph nodes, reducing their migration into the central nervous system and gastrointestinal tract, thereby lowering inflammation in MS and UC.

Manufacturer in the USA, Mexico, and Canada

  • United States: Bristol Myers Squibb (BMS).
  • Canada: Bristol Myers Squibb Canada Co.
  • Mexico: Bristol Myers Squibb de México, S. de R.L. de C.V.

Available Strengths and Dosage Forms – United States, Mexico, and Canada

Country Comparison – United States vs Mexico and Canada

  • Approved in all three countries for relapsing MS and ulcerative colitis.
  • Canada and Mexico may have different prescribing guidelines and reimbursement pathways.

Average Retail Price (Monthly Treatment) USA vs Mexico vs Canada

• Canada: Typically 25–35% savings compared to U.S. pricing.
• Mexico: Typically 30–40% savings compared to U.S. pricing.
Savings are approximate, based on 2025 price data. They may vary depending on availability, prescription requirements, and insurance coverage.

Where to Buy USA

  • Costco
  • CVS
  • Rite Aid
  • Walgreens
  • Walmart
  • Kroger
  • Albertsons
  • Sam’s Club
  • Publix
  • Target (via CVS Pharmacy)
  • Online mail-order specialty care pharmacies

Note: Typically dispensed through specialty pharmacies due to monitoring requirements.

Storage Requirements

  • Store at room temperature (20°C–25°C / 68°F–77°F).
  • Protect from moisture and light.
  • Keep medication in original packaging until use.

Shipping from Canada

This medication is accessed through fully licensed Canadian pharmacies regulated by Health Canada. All pharmacies included in the MedicalMex network undergo a rigorous review and verification process to ensure compliance with national standards, patient safety, and medication authenticity.

  • Prescription verification and fulfillment coordination
  • Secure, compliant medication logistics
  • Access to licensed Canadian pharmacists
  • Access to our network of certified physicians if a Telehealth consultation is needed
  • Case management, payment handling, and personalized boutique-level support
  • Cold chain shipping with next-generation temperature-monitored coolers, when required
  • Refill tracking and patient adherence programs

You are working directly with MedicalMex Inc., a U.S.-based company that helps eligible patients safely access affordable medications from Canada — with compliance and full-service concierge support at every step.

Buying from Mexico

This medication is also available through certified pharmacies in Mexico regulated by COFEPRIS (Mexico’s national health authority). All partners in the MedicalMex network must pass a rigorous review and certification process before being approved for patient access.

  • Transportation support to our affiliate clinic in Tijuana, Mexico
  • Prescription handling through licensed physicians within our certified network
  • Access to our network of accredited physicians if a Telehealth consultation is needed
  • Travel coordination, including flights and/or hotel reservations when required
  • Travel insurance
  • Cold chain shipping with advanced temperature-monitored coolers, when applicable
  • Personalized, boutique-level service
  • Refill tracking and patient adherence support

You are working directly with MedicalMex Inc., a U.S.-based company that manages every detail — from medical and travel logistics to prescription compliance — providing secure, affordable access to life-saving medications from Mexico.

Key Benefits

  • Reduces relapse rates and slows progression in relapsing MS.
  • Oral therapy — convenient alternative to injections or infusions.
  • Effective for both MS and ulcerative colitis, providing broader therapeutic coverage.
  • May improve quality of life by reducing disease activity.

Side Effects

Common side effects:

  • Upper respiratory tract infections
  • Headache
  • Hypertension (high blood pressure)
  • Back pain
  • Elevated liver enzymes

Serious but less common side effects:

  • Bradycardia (slow heart rate) upon initiation
  • Increased risk of infections
  • Macular edema (swelling in the eye)
  • Rare liver injury
  • Respiratory effects (shortness of breath, cough)

Warnings and Precautions

  • Requires baseline evaluation before starting: EKG, liver function tests, and eye exam in at-risk patients.
  • Increased risk of serious infections; avoid live vaccines.
  • Monitor for signs of liver damage, macular edema, and pulmonary function changes.
  • Safety not established in pregnancy or breastfeeding.

Alternative Medications (by Indication)

  • Gilenya (fingolimod): Another S1P receptor modulator.
  • Mavenclad (cladribine): Oral treatment for relapsing MS.
  • Tecfidera (dimethyl fumarate): Oral MS therapy.
  • Stelara (ustekinumab): Biologic used in ulcerative colitis.
  • Entyvio (vedolizumab): Biologic for ulcerative colitis.

Medication FAQs

Zeposia is prescribed for adults with relapsing multiple sclerosis and ulcerative colitis.
It is taken orally once daily as a capsule.
Some patients notice improvements within weeks, but full therapeutic effect may take several months.
Yes. Regular blood tests, eye exams, and blood pressure checks may be required.
Live vaccines should be avoided during treatment and for 3 months afterward.

No. Its use is not recommended during pregnancy or breastfeeding.
Yes. Macular edema is a potential side effect, especially in diabetic or uveitis patients.
It is not approved for pediatric use.
Yes. It reduces lymphocyte circulation, lowering immune system activity.
Yes. Patient support programs may exist in the U.S., Canada, and Mexico. MedicalMex helps patients explore affordable access options.